| RS1205909298 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1205920781 |
KIZ
|
Health Risk |
Likely pathogenic |
— |
| RS1205964567 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1205971311 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Infantile hypophosphatasia |
| RS1205972630 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS12059860 |
CYP4B1
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS1205986855 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1205989324 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
— |
| RS1205990349 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type A |
| RS1206001509 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS1206002281 |
GPC3
|
Health Risk |
Likely pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Simpson-Golabi-Behmel syndrome type 1 |
| RS1206013600 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1206016866 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS1206030542 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1206044252 |
TPM1
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1Y, Dilated cardiomyopathy 1Y |
| RS1206061120 |
FKBP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Bruck syndrome 1, FKBP10-related disorder |
| RS1206062430 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spastic paraplegia |
| RS1206062558 |
TTLL5
|
Health Risk |
Likely pathogenic |
— |
| RS1206078224 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1206089987 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1206101901 |
AUTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1206108637 |
FECH
|
Health Risk |
Likely pathogenic |
— |
| RS1206116606 |
MEGF8
|
Health Risk |
Pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS1206116722 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS1206136415 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1206142672 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS1206153335 |
USP9X
|
Health Risk |
Pathogenic |
— |
| RS1206160345 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS1206163048 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1206165503 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Hereditary cancer-predisposing syndrome |
| RS1206168005 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1206185362 |
LRBA
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1206206296 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1206214608 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1206217022 |
SH3TC2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1206233497 |
POMT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS1206249850 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS1206301205 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Naxos disease |
| RS1206309859 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS1206321984 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1206358847 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1206365367 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1206374036 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1206396303 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1206413996 |
ALG12
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS1206423781 |
OPTN
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS1206425661 |
SLC3A1
|
Health Risk |
Likely pathogenic |
Cystinuria, Cystinuria |
| RS1206452899 |
GGCX
|
Health Risk |
Pathogenic |
— |
| RS1206472219 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1206472792 |
WRAP53
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1206475365 |
COL11A2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1206476337 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1206478143 |
OPTN
|
Health Risk |
Pathogenic |
— |
| RS1206491725 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS1206504105 |
PDZD7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1206508060 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1206511483 |
TSHR
|
Health Risk |
Pathogenic |
TSHR-related disorder, TSHR-related disorder |
| RS1206517501 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1206559440 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS1206562843 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS1206574200 |
RDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis, Leber congenital amaurosis 13 |
| RS1206578296 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1206609823 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1206639344 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Inborn genetic diseases |
| RS1206662571 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiovascular phenotype |
| RS1206678898 |
OBSCN
|
Health Risk |
Pathogenic |
OBSCN-related disorder, OBSCN-related disorder |
| RS1206723575 |
CEP290
|
Health Risk |
Likely pathogenic |
— |
| RS1206731716 |
MESP2
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS1206753537 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, IFT140-related disorder |
| RS1206778631 |
UBR1
|
Health Risk |
Pathogenic |
— |
| RS1206810310 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1206813753 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1206838893 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1206843725 |
FBN2
|
Health Risk |
Pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1206861190 |
EYS
|
Health Risk |
Likely pathogenic |
— |
| RS1206863775 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS1206865525 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS12068754 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS1206881555 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1206884190 |
SMARCC2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 8, Coffin-Siris syndrome 8 |
| RS1206884841 |
POMK
|
Health Risk |
Pathogenic |
Limb-girdle muscular dystrophy due to POMK deficiency, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1206933109 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1206950481 |
ANO10
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS1206951756 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1206977063 |
FOXG1
|
Health Risk |
Conflicting classifications of pathogenicity |
FOXG1 disorder, Inborn genetic diseases |
| RS1206985138 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1206991395 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1207050293 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS1207051921 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1207080512 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1207085497 |
MYBPC1
|
Health Risk |
Likely pathogenic |
— |
| RS1207096732 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1207102247 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Ovarian cancer |
| RS1207105923 |
NKX6-2
|
Health Risk |
Likely pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS1207122491 |
TMC1
|
Health Risk |
Likely pathogenic |
TMC1-related disorder, TMC1-related disorder |
| RS1207142968 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS1207147043 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1207174167 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1207177925 |
DPYD
|
Health Risk |
Pathogenic/Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, See cases |
| RS1207202747 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |